Trials / Completed
CompletedNCT05097924
Gastrointestinal Tolerability of a Partially Hydrolyzed Ready-to-feed Infant Formula in Healthy Newborns
Gastrointestinal Tolerability of a Partially Hydrolyzed, Whey-based, Ready-to-feed Infant Formula in Healthy Newborns During the Birth Hospitalization Period: a Post-market Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 0 Months – 24 Months
- Healthy volunteers
- —
Summary
Gastrointestinal tolerability of a partially hydrolyzed, whey-based, ready-to-feed infant formula in healthy newborns during the birth hospitalization period: a post-market study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | NAN Supreme HypoAllergenic Starter Infant Formula in ready-to-feed format | Post-market observational study with formula feeding administered via standard of care |
Timeline
- Start date
- 2022-02-01
- Primary completion
- 2022-03-09
- Completion
- 2022-03-09
- First posted
- 2021-10-28
- Last updated
- 2022-07-06
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT05097924. Inclusion in this directory is not an endorsement.